Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Fosamax.

This drug had not previously been considered by the PBAC for this indication. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific ...

Alendronate sodium is the generic version of Merck’s Fosamax tablets, indicated for the treatment of osteoporosis in postmenopausal women. Alendronate sodium is also indicated to increase bone mass in ...

Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, according to recent data published in the Archives of Internal Medicine. Researchers from ...

FDA has approved Binosto (alendronate sodium) Effervescent Tablets for the treatment of osteoporosis in postmenopausal women, and to increase bone mass in men with osteoporosis.

Under the terms of a supply agreement, Merck will manufacture and supply the alendronate sodium tablets to Watson, which will market, sell and distribute the product in the United States. Merck ...

EffRx Pharmaceuticals SA is proud to announce that BINOSTO™ (alendronate sodium) Effervescent Tablet for buffered oral solution (70 mg) is now available by prescription in the United States.

Alendronate Sodium Tablets are the generic equivalent of Merck's Fosamax Tablets. The product is indicated for the treatment and prevention of osteoporosis in postmenopausal women and the ...

BANGALORE, Sept 12 (Reuters) - India's Sun Pharmaceutical Industries said it has received approval from the U.S. Food and Drug Administration to market alendronate sodium tablets, the generic ...

DDS No. 36-7-xxxx [17 pp.] Fosamax (Alendronate Sodium) is approved by the U.S. Food and Drug Administration for the treatment and prevention of postmenopausal osteoporosis.

Bisphosphonates for the treatment and prevention of osteoporosis include: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets by Merck ...